The intensity of the fluorescent signals (Rh6G-EGCG and DX) at the tumor site significantly increased locally within 24.0 h, indicating continuous and sustained drug delivery by NPs targeting P-selectin and CD44 in the tumor. Here, CD44 is linked to neoplasm.